Global Animal Biotechnology Market Size By Type (Diagnostic Tests, Drugs), By Application (Preventive Care for Animals, Development of Animal Pharmaceuticals), By Region, And Segment Forecasts, 2023 t...

The Global Animal Biotechnology Market was valued at USD 26.7 billion in 2023 and is projected to reach USD 48.5 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2023–2031). This growth is driven by increasing demand for animal-based protein, advancements in genetic engineering and cloning, and a rising focus on animal health and productivity. Animal biotechnology plays a crucial role in improving breeding efficiency, disease resistance, and nutritional value, which directly impacts food security and sustainability.

Drivers:

1. Increasing Demand for Animal Protein:

Rising global consumption of meat, dairy, and other animal-derived products has intensified the need for biotechnological solutions to enhance animal yield and efficiency.

2. Advancements in Genetic Engineering:

Technologies such as CRISPR, recombinant DNA, and cloning are revolutionizing animal biotechnology by enabling precise genetic modifications, resulting in better traits and reduced disease susceptibility.

3. Enhanced Focus on Animal Health:

Biotechnology is being increasingly adopted to develop advanced diagnostics, vaccines, and therapeutics aimed at preventing and managing animal diseases, ensuring healthier livestock populations.

Restraints:

1. Ethical and Regulatory Concerns:

The application of genetic engineering in animals often raises ethical debates and is subject to stringent regulatory scrutiny, particularly in regions like Europe and North America.

2. High R&D Costs:

Developing biotech solutions for animals involves extensive research, trials, and regulatory approvals, leading to high upfront investments and longer time-to-market cycles.

Opportunity:

1. Emerging Markets and Livestock Expansion:

Countries in Asia-Pacific and Latin America are witnessing rapid livestock growth and are investing heavily in animal health technologies, providing lucrative expansion opportunities for market players.

2. Integration of Big Data and AI in Animal Genomics:

Advanced data analytics and AI are being used to decode animal genomes faster and more cost-effectively, enabling precise breeding and health monitoring.

3. Rise of Companion Animal Biotechnology:

Growing pet ownership and increasing spending on companion animal care are opening new frontiers in veterinary biotechnology for pet diagnostics, vaccines, and wellness solutions.

Market by System Type Insights:

In 2023, the Genetically Modified Animal segment held the largest share of the market. Innovations in genetic manipulation have improved livestock productivity, disease resistance, and feed efficiency. This segment continues to lead due to growing acceptance and economic advantages in animal agriculture.

The Biotech-Derived Vaccines and Diagnostics segment is anticipated to witness the fastest growth, driven by increasing concerns over zoonotic diseases and a proactive stance on animal health and biosecurity globally.

Market by End-use Insights:

Livestock Production emerged as the leading end-use segment, accounting for the majority of revenue in 2023. Applications such as embryo transfer, artificial insemination, and genetic screening are widely adopted in the livestock sector.

Meanwhile, the Veterinary Clinics and Research Institutes segment is rapidly growing, thanks to a surge in animal health research and the development of customized veterinary therapeutics and diagnostics.

Market by Regional Insights:

North America led the global animal biotechnology market in 2023, owing to robust R&D infrastructure, strong regulatory frameworks, and high adoption of advanced biotechnology in animal agriculture.

Asia-Pacific is forecasted to experience the highest CAGR during the forecast period. This growth is propelled by increasing livestock population, rising disposable income, and expanding investments in animal biotechnology in countries such as China, India, and Vietnam.

Competitive Scenario:

Key players in the Global Animal Biotechnology Market include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Merck Animal Health, Ceva Santé Animale, Genus plc, Virbac, Idexx Laboratories, Thermo Fisher Scientific, and Heska Corporation. These companies are focusing on:

Expanding biotech-based animal health portfolios

Strategic mergers and acquisitions

Investing in genetic improvement programs and precision livestock farming

Recent Developments:

2024: Elanco introduced a new biotech vaccine targeting porcine reproductive and respiratory syndrome virus (PRRSV).

2023: Zoetis partnered with a leading AI genomics firm to enhance trait selection in cattle breeding programs.

2023: Genus plc announced the commercialization of its CRISPR gene-edited pigs with resistance to porcine reproductive diseases in select markets.

Scope of Work – Global Animal Biotechnology Market

FAQs:

1. What is the current market size of the Global Animal Biotechnology Market?

The Global Animal Biotechnology Market was valued at USD 26.7 billion in 2023.

2. What is the major growth driver of the Global Animal Biotechnology Market?

The major growth driver is the rising global demand for animal-based protein and advancements in genetic engineering technologies.

3. Which is the largest region during the forecast period in the Global Animal Biotechnology Market?

North America is the largest region due to advanced R&D and early adoption of biotechnology in animal health.

4. Which segment accounted for the largest market share in the Global Animal Biotechnology Market?

The Genetically Modified Animal segment accounted for the largest share in 2023.

5. Who are the key market players in the Global Animal Biotechnology Market?

Key players include Zoetis, Elanco, Boehringer Ingelheim, Merck Animal Health, and Genus plc.